Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

Merck (MRK) reported fourth quarter and full-year earnings Tuesday ... That includes GLP-1s, of course. Follow Anjalee on ...

Merck Foundation Fashion Awards 2023 Winners Announced to Acknowledge their Work to Empower Infertile Women and Support Girl ...

This $15M payment marks the second milestone achieved in the collaboration with Merck. Under the agreement, Neuphoria is ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, though the drug company’s outlook for 2025 ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings. Its full-year revenue and EPS guidance missed by ...

With an estimated 32,000 Canadians diagnosed with lung cancer in 2024, Merck Canada aims to promote lung health with a new self-assessment tool. Lung cancer is the most commonly diagnosed cancer ...